174
Views
31
CrossRef citations to date
0
Altmetric
Drug Evaluation

Rubitecan

Pages 71-79 | Published online: 22 Dec 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Endika Martín-Encinas, Asier Selas, Francisco Palacios & Concepción Alonso. (2022) The design and discovery of topoisomerase I inhibitors as anticancer therapies. Expert Opinion on Drug Discovery 17:6, pages 581-601.
Read now
Ammar D. Elmezayen, Anas Al-Obaidi, Alp Tegin Şahin & Kemal Yelekçi. (2021) Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics 39:8, pages 2980-2992.
Read now

Articles from other publishers (28)

Xin Wang, Chao Yang, Mengya Liao, Yongmei Xie & Jinliang Yang. (2023) Synthesis and In Vitro Anti-tumor Evaluation of Novel Glycoconjugated SN38 Derivatives. Chemistry Letters 52:10, pages 788-790.
Crossref
Katarzyna Strzelecka, Urszula Piotrowska, Marcin Sobczak & Ewa Oledzka. (2023) The Advancement of Biodegradable Polyesters as Delivery Systems for Camptothecin and Its Analogues—A Status Report. International Journal of Molecular Sciences 24:2, pages 1053.
Crossref
Tian-Miao Ou, Jia-Wei Sun, Xiao-Na Wang & Jing Zou. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery 81 104 .
Liangliang Song, Zhenwei Lv, Kui Zhang, Yile Wu, Erik V. Van der Eycken & Lingchao Cai. (2022) Recent Advances in the Asymmetric Total Synthesis of Camptothecin. Asian Journal of Organic Chemistry 11:11.
Crossref
Lucca Policastro, Isabela Dolci, Andre Godoy, José Silva Júnior, Uriel Ruiz, Igor Santos, Ana Jardim, Kirandeep Samby, Jeremy Burrows, Timothy Wells, Laura Gil, Glaucius Oliva & Rafaela Fernandes. (2022) The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication. Viruses 14:7, pages 1351.
Crossref
Frederick A. Partridge, Beth C. Poulton, Milly A. I. Lake, Rebecca A. Lees, Harry-Jack Mann, Gareth J. Lycett & David B. Sattelle. (2021) Actions of Camptothecin Derivatives on Larvae and Adults of the Arboviral Vector Aedes aegypti. Molecules 26:20, pages 6226.
Crossref
Ruo-Jun Man, Nasreen Jeelani, Chongchen Zhou & Yu-Shun Yang. (2021) Recent Progress in the Development of Quinoline Derivatives for the Exploitation of Anti-Cancer Agents. Anti-Cancer Agents in Medicinal Chemistry 21:7, pages 825-838.
Crossref
Ariane Sternberg, Dwight L. McKee & Cord Naujokat. (2020) Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery. Current Topics in Medicinal Chemistry 20:16, pages 1423-1433.
Crossref
Dorota Olender, Justyna Żwawiak & Lucjusz Zaprutko. (2018) Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines. Pharmaceuticals 11:2, pages 54.
Crossref
Pablo Botella & Eva Rivero-Buceta. (2017) Safe approaches for camptothecin delivery: Structural analogues and nanomedicines. Journal of Controlled Release 247, pages 28-54.
Crossref
Emanuela Martino, Serena Della Volpe, Elisa Terribile, Emanuele Benetti, Mirena Sakaj, Adriana Centamore, Andrea Sala & Simona Collina. (2017) The long story of camptothecin: From traditional medicine to drugs. Bioorganic & Medicinal Chemistry Letters 27:4, pages 701-707.
Crossref
Carmen Avendaño & J. Carlos Menéndez. 2015. Medicinal Chemistry of Anticancer Drugs. Medicinal Chemistry of Anticancer Drugs 273 323 .
Jabeena Khazir, Darren L. Riley, Lynne A. Pilcher, Pieter De-Maayer & Bilal Ahmad Mir. (2014) Anticancer Agents from Diverse Natural Sources. Natural Product Communications 9:11, pages 1934578X1400901.
Crossref
Jabeena Khazir, Bilal Ahmad Mir, Lynne Pilcher & Darren L. Riley. (2014) Role of plants in anticancer drug discovery. Phytochemistry Letters 7, pages 173-181.
Crossref
Raj Kumar Shukla. (2013) Recent advances in oral anticancer agents for colon cancer. Future Oncology 9:12, pages 1893-1908.
Crossref
Carrie J. LovittTodd B. ShelperVicky M. Avery. (2013) Miniaturized Three-Dimensional Cancer Model for Drug Evaluation. ASSAY and Drug Development Technologies 11:7, pages 435-448.
Crossref
Silvia Mazzaferro, Kawthar Bouchemal & Gilles Ponchel. (2013) Oral delivery of anticancer drugs II: the prodrug strategy. Drug Discovery Today 18:1-2, pages 93-98.
Crossref
W.A. Denny. 2013. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.
Karol Michał Kacprzak. 2013. Natural Products. Natural Products 643 682 .
Nelson S. Yee. 2013. Impact of Genetic Targets on Cancer Therapy. Impact of Genetic Targets on Cancer Therapy 91 143 .
Kuo‐Hsiung Lee, Hideji Itokawa, Toshiyuki Akiyama & Susan L. Morris‐Natschke. 2012. Natural Products in Chemical Biology. Natural Products in Chemical Biology 351 388 .
Hideji Itokawa, Susan L. Morris-Natschke, Toshiyuki Akiyama & Kuo-Hsiung Lee. (2008) Plant-derived natural product research aimed at new drug discovery. Journal of Natural Medicines 62:3, pages 263-280.
Crossref
Francesco Caponigro, Giacomo Cartenì, Jean Pierre Droz, Amalia Milano, Wayne B. Davis & Patricia Pollard. (2007) Phase II study of rubitecan in recurrent or metastatic head and neck cancer. Cancer Chemotherapy and Pharmacology 62:2, pages 209-214.
Crossref
Tadhg P. BegleyKuo‐Hsiung Lee, Hideji Itokawa, Toshiyuki Akiyama & Susan L. Morris‐Natschke. 2007. Wiley Encyclopedia of Chemical Biology. Wiley Encyclopedia of Chemical Biology 1 22 .
G Allegrini, A Falcone, A Fioravanti, M T Barletta, P Orlandi, F Loupakis, E Cerri, G Masi, A Di Paolo, R S Kerbel, R Danesi, M Del Tacca & G Bocci. (2008) A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients. British Journal of Cancer 98:8, pages 1312-1319.
Crossref
Carmen Avendaño & J. Carlos Menéndez. 2008. Medicinal Chemistry of Anticancer Drugs. Medicinal Chemistry of Anticancer Drugs 199 228 .
Muriel Cuendet & John M. Pezzuto. 2007. Modern Alkaloids. Modern Alkaloids 25 52 .
Sabrina Dallavalle & Lucio Merlini. 2007. Modern Alkaloids. Modern Alkaloids 503 520 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.